Zhou, Shuangshuang, Meiyi Deng, Xuyu Bian, Jindong Shi, Rongrui Liang, and Min Tao. “Synergistic Anti-Tumor Effects of Lenalidomide and Gefitinib by Upregulating ADRB2 and Inactivating the mTOR/PI3K/AKT Signaling Pathway in Lung Adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD”. Cellular and Molecular Biology 70, no. 2 (February 29, 2024): 120–127. Accessed November 23, 2024. https://cellmolbiol.org/index.php/CMB/article/view/5253.